Free public records show Kang Stem Biotech Co., Ltd. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Kang Stem Biotech Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
4 active studies led by Kang Stem Biotech Co., Ltd., of 19 in all
Source: ClinicalTrials.gov, Studies with Kang Stem Biotech Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Kang Stem Biotech Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Kang Stem Biotech Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Kang Stem Biotech Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Kang Stem Biotech Co., Ltd. is in.
Stories on the topics Kang Stem Biotech Co., Ltd. works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
Read
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
ReadSearch all reports for Kang Stem Biotech Co., Ltd. All companies